This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Rhodes Technologies, Other. Active years: 2012-2015.
Company Filing History:
1 out of 47 
1 out of 834,453 Years Active: 2012-2015
Title: Innovations by Kenneth C. Slater
Introduction
Kenneth C. Slater is an accomplished inventor based in Manchester, MA (US). He has made significant contributions to the field of medical science, particularly in methods for eliminating chemical substances from the blood. With a total of 2 patents to his name, Slater's work has the potential to impact therapeutic practices significantly.
Latest Patents
Slater's latest patents focus on innovative methods and dosage regimens for reducing the concentration of chemical substances in blood plasma. The first patent describes a method that involves titrating an initial peak concentration of a chemical or drug substance in the blood for a predefined dosing period. It also includes titrating the lowest concentration level of the substance immediately before the end of the dosing period. This method ensures that the lowest concentration level for subsequent dosing periods is decreased by no more than five percent of the previous period's lowest concentration, extending the overall treatment duration to seventy days or more. The second patent similarly targets receptors in the central or peripheral nervous system, employing a comparable titration method to achieve effective results.
Career Highlights
Throughout his career, Kenneth C. Slater has worked with notable companies, including Rhodes Technologies. His experience in these organizations has contributed to his expertise in developing innovative solutions in the medical field.
Collaborations
Slater has collaborated with professionals such as Brenda E. Richardson and Scott M. Connors. These partnerships have likely enriched his work and expanded the scope of his inventions.
Conclusion
Kenneth C. Slater's contributions to medical science through his patents demonstrate his commitment to innovation and improving health outcomes. His work continues to pave the way for advancements in therapeutic methods.